Levodopa, involuntary movements and fusaric acid.
D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism*; D006801:Humans; D009069:Movement Disorders / Q000517:prevention & control*; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D010300:Parkinson Disease / Q000188:drug therapy*; D010848:Picolinic Acids / Q000008:administration & dosage / Q000494:pharmacology*
D010848:Picolinic Acids; D004295:Dihydroxyphenylalanine; D009638:Norepinephrine